Versant Venture Capital Vi, L.P. Graphite Bio, Inc. (GRPH) insider trading activity

GRPH Quotes by TradingView

Versant Venture Capital VI, L.P. Transaction History

Date Transaction Value Shares Traded Form
Mar 21 2024
BUY
Other acquisition or disposition
-
598,203
Jun 29 2021
BUY
Conversion of derivative security
-
1,527,719
Jun 29 2021
BUY
Open market or private purchase
$3,060,000 $17.0 p/Share
180,000

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
> 10% Shareholder
OYST
Oyster Point Pharma, Inc. Healthcare
> 10% Shareholder
IPSC
Century Therapeutics, Inc. Healthcare
> 10% Shareholder
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
> 10% Shareholder
TPST
Tempest Therapeutics, Inc. Healthcare
VVC

Versant Venture Capital Vi, L.P.

San Francisco, CA

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GRPH